Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive … Read more
Senzime AB - Asset Resilience Ratio
Senzime AB (SEZI) has an Asset Resilience Ratio of 20.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Senzime AB's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Senzime AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr73.97 Million | 20.0% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr73.97 Million | 20.00% |
Asset Resilience Insights
- Good Liquidity Position: Senzime AB maintains a healthy 20.00% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Senzime AB Industry Peers by Asset Resilience Ratio
Compare Senzime AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Senzime AB (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Senzime AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 20.00% | Skr73.97 Million | Skr369.81 Million | -3.77pp |
| 2024-12-31 | 23.78% | Skr100.94 Million | Skr424.53 Million | -11.05pp |
| 2023-12-31 | 34.83% | Skr151.01 Million | Skr433.54 Million | +26.76pp |
| 2022-12-31 | 8.07% | Skr26.04 Million | Skr322.68 Million | -34.81pp |
| 2021-12-31 | 42.88% | Skr74.87 Million | Skr174.62 Million | -19.04pp |
| 2020-12-31 | 61.92% | Skr160.31 Million | Skr258.89 Million | +45.47pp |
| 2019-12-31 | 16.46% | Skr30.90 Million | Skr187.76 Million | -0.11pp |
| 2018-12-31 | 16.57% | Skr32.67 Million | Skr197.16 Million | +11.31pp |
| 2017-12-31 | 5.26% | Skr8.74 Million | Skr166.03 Million | -1.15pp |
| 2016-12-31 | 6.41% | Skr10.03 Million | Skr156.31 Million | -- |